Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-12

Clinical Trial Update: Study of Temozolomide to Treat Newly Diagnosed Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial of temozolomide for newly diagnosed brain metastases was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)

Snippet

Sponsor: University of Florida | Conditions: Brain Metastases | Phase 2 | Status: TERMINATED | Results posted: 2012-07-12